A CDC/AHA workshop examined the selection and use of inflammatory markers to predict cardiovascular disease risk, providing recommendations for clinical and public health practice.
Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice was convened on March 14 and 15, 2002, in Atlanta, Ga, to examine the selection and use of inflammatory markers to predict cardiovascular disease (CVD) risk. Three discussion groups on issues related to laboratory, clinical, and population science were organized. The present report contains a summary of the discussions and recommendations of the clinical practice discussion group.
Smith et al. (2004) studied Cardiovascular disease. Inflammatory markers was evaluated. A CDC/AHA workshop examined the selection and use of inflammatory markers to predict cardiovascular disease risk, providing recommendations for clinical and public health practice.